Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol

Endogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remain...

Full description

Bibliographic Details
Main Authors: Xin Chen, Bo-lun Shi, Run-zhi Qi, Xing Chang, Hong-gang Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/full
_version_ 1818643708601434112
author Xin Chen
Xin Chen
Bo-lun Shi
Run-zhi Qi
Xing Chang
Xing Chang
Hong-gang Zheng
Hong-gang Zheng
Hong-gang Zheng
author_facet Xin Chen
Xin Chen
Bo-lun Shi
Run-zhi Qi
Xing Chang
Xing Chang
Hong-gang Zheng
Hong-gang Zheng
Hong-gang Zheng
author_sort Xin Chen
collection DOAJ
description Endogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remains unclear. In the present study, we investigated the therapeutic effects and the underlying molecular mechanisms of HNK on colorectal cancer in a mouse model (ApcMin/+) by analyzing the urine metabolic profile based on metabolomics, which is a powerful tool for characterizing metabolic disturbances. We found that potential urine biomarkers were involved in the metabolism of compounds such as purines, tyrosines, tryptophans, etc. Moreover, we showed that a total of 27 metabolites were the most contribution biomarkers for intestinal tumors, and we found that the citrate cycle (TCA cycle) was regulated by HNK. In addition, it was suggested that the efficacy of HNK was achieved by affecting the multi-pathway system via influencing relevant metabolic pathways and regulating metabolic function. Our work also showed that high-throughput metabolomics can characterize the regulation of metabolic disorders as a therapeutic strategy to prevent colorectal cancer.
first_indexed 2024-12-17T00:03:15Z
format Article
id doaj.art-af65a929c57540aa94f5da7a89175f53
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T00:03:15Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-af65a929c57540aa94f5da7a89175f532022-12-21T22:11:01ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.671014671014Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of HonokiolXin Chen0Xin Chen1Bo-lun Shi2Run-zhi Qi3Xing Chang4Xing Chang5Hong-gang Zheng6Hong-gang Zheng7Hong-gang Zheng8Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaChina Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaChina Academy of Chinese Medical Sciences, Beijing, ChinaGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaEndogenous metabolites are a class of molecules playing diverse and significant roles in many metabolic pathways for disease. Honokiol (HNK), an active poly-phenolic compound, has shown potent anticancer activities. However, the detailed crucial mechanism regulated by HNK in colorectal cancer remains unclear. In the present study, we investigated the therapeutic effects and the underlying molecular mechanisms of HNK on colorectal cancer in a mouse model (ApcMin/+) by analyzing the urine metabolic profile based on metabolomics, which is a powerful tool for characterizing metabolic disturbances. We found that potential urine biomarkers were involved in the metabolism of compounds such as purines, tyrosines, tryptophans, etc. Moreover, we showed that a total of 27 metabolites were the most contribution biomarkers for intestinal tumors, and we found that the citrate cycle (TCA cycle) was regulated by HNK. In addition, it was suggested that the efficacy of HNK was achieved by affecting the multi-pathway system via influencing relevant metabolic pathways and regulating metabolic function. Our work also showed that high-throughput metabolomics can characterize the regulation of metabolic disorders as a therapeutic strategy to prevent colorectal cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/fullmetabolomicsbiomarkersmetabolitesultra-performance liquid chromatographymass spectrometry
spellingShingle Xin Chen
Xin Chen
Bo-lun Shi
Run-zhi Qi
Xing Chang
Xing Chang
Hong-gang Zheng
Hong-gang Zheng
Hong-gang Zheng
Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
Frontiers in Oncology
metabolomics
biomarkers
metabolites
ultra-performance liquid chromatography
mass spectrometry
title Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
title_full Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
title_fullStr Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
title_full_unstemmed Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
title_short Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
title_sort ultra performance liquid chromatography mass spectrometry based metabolomics for discovering potential biomarkers and metabolic pathways of colorectal cancer in mouse model apcmin and revealing the effect of honokiol
topic metabolomics
biomarkers
metabolites
ultra-performance liquid chromatography
mass spectrometry
url https://www.frontiersin.org/articles/10.3389/fonc.2021.671014/full
work_keys_str_mv AT xinchen ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT xinchen ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT bolunshi ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT runzhiqi ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT xingchang ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT xingchang ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol
AT honggangzheng ultraperformanceliquidchromatographymassspectrometrybasedmetabolomicsfordiscoveringpotentialbiomarkersandmetabolicpathwaysofcolorectalcancerinmousemodelapcminandrevealingtheeffectofhonokiol